• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ADVANCED STERILIZATION PRODUCTS CYCLESURE® BIO INDICATOR; INDICATOR, BIOLOGICAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ADVANCED STERILIZATION PRODUCTS CYCLESURE® BIO INDICATOR; INDICATOR, BIOLOGICAL Back to Search Results
Catalog Number 14324
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 04/26/2019
Event Type  malfunction  
Manufacturer Narrative
Initial reporter phone #: (b)(6).(b)(4).Test specifications for product release were met.No issues were observed in the dhr that would contribute to the complaint.Asp complaint ref #: (b)(4).
 
Event Description
A customer reported a positive result with a cyclesure® 24 biological indicator (bi) after a completed sterrad® cycle.The affected load was released and used on a patient.There was no report of infection, injury or harm to patient(s) associated with this issue.Although there is no report of patient injury or harm and no prior incidents have resulted in serious injury, advanced sterilization products (asp) has determined in this situation sterility cannot be assured.Therefore, as a matter of policy asp had decided to report all incidents of positive cyclesure® 24 biological indicators when the load has been released and used on patient(s) prior to reprocessing.
 
Manufacturer Narrative
It was initially reported that the load was released and used on a patient; however, the affiliate later confirmed that the load was recalled/reprocessed.H3: asp investigation summary: the investigation included a review of the device history record (dhr), trending of lot number, system risk analysis (sra), visual analysis and retains analysis.Trending analysis by lot number was reviewed from 11/09/2018 to 04/27/2019 and trending was not exceeded.The sra indicates the risk associated with a quality problem with no impact on safety is "low." the single cyclesure® 24 bi was not available for return and visual analysis.Thirty-two retains bis were subject to functional evaluation.All thirty-two bis met specification.The suspect positive bi issue could not be confirmed as the suspect product was not available for return and visual analysis.There is no evidence to suggest an alleged deficiency since the dhr review found no anomalies that would contribute to a positive bi result, retains product met functional specifications and lot history review did not show any significant trend.The issue will continue to be tracked and trended.Asp complaint ref #: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CYCLESURE® BIO INDICATOR
Type of Device
INDICATOR, BIOLOGICAL
Manufacturer (Section D)
ADVANCED STERILIZATION PRODUCTS
33 technology drive
irvine CA 92618
MDR Report Key9276071
MDR Text Key177816212
Report Number2084725-2019-00981
Device Sequence Number1
Product Code FRC
UDI-Device Identifier10705037016211
UDI-Public10705037016211
Combination Product (y/n)N
PMA/PMN Number
K994055
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 10/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/31/2019
Device Catalogue Number14324
Device Lot Number31318099
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 10/11/2019
Initial Date FDA Received11/04/2019
Supplement Dates Manufacturer Received11/06/2019
Supplement Dates FDA Received11/15/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-